可改变生活方式因素与循环抗苗勒管激素关联的系统综述
该预注册系统综述检索Embase和PubMed至2023年11月1日,纳入65项研究,评估BMI、吸烟、口服避孕药使用、饮酒、咖啡因摄入、体力活动和腰臀比与循环抗苗勒管激素(AMH)水平的关联。多数研究报道BMI、吸烟、口服避孕药使用和体力活动与AMH呈显著负相关,而腰臀比、饮酒和咖啡因使用多数研究未发现关联;所有决定因素的效应量均存在异质性。
要点
- BMI、吸烟、口服避孕药使用和体力活动多数研究显示与AMH水平呈显著负相关。
- 腰臀比、饮酒和咖啡因使用多数研究未发现与AMH水平存在关联。
- 所有决定因素的效应量均存在异质性,解读个体AMH测量时应考虑生活方式因素。
核心结论
- 生活方式因素与AMH水平差异相关,解读个体AMH测量时应予以考虑。
- AMH水平可受生活方式行为改变的影响,可作为临床和生活方式咨询的有用工具。
- 观察到的AMH差异与真实卵巢储备之间关系的性质仍有待评估。
研究设计与样本
- 预注册系统综述,检索Embase和PubMed截至2023年11月1日,纳入在成年女性中评估至少一种感兴趣生活方式因素与AMH关联的研究。
- 共识别15072条记录,65项研究符合纳入标准,其中66.2%的研究采用横断面设计。
- 使用美国国家心肺血液研究所的研究质量评估工具评价纳入研究质量。
- PROSPERO注册号:CRD42022322575。
主要发现
- BMI、吸烟、口服避孕药使用和体力活动多数研究报告与AMH水平呈显著负相关。
- 腰臀比、饮酒和咖啡因使用多数研究未发现与AMH的关联。
- 在发现显著负相关的研究中,BMI每增加一个单位AMH平均差异范围为-0.015至-0.2 ng/ml。
- 当前吸烟者与非吸烟者相比,AMH平均差异范围为-0.4至-1.1 ng/ml,相对差异范围为-4%至-44%。
- 当前口服避孕药使用者的AMH相对平均差异范围为-17%至-31.1%,另有研究报道年龄标准化百分位下降11个及使用9周后平均下降1.97 ng/ml。
临床怎么用
- 原文指出生活方式因素与AMH水平差异相关,解读个体AMH测量时应予以考虑。
- 原文指出AMH水平可受生活方式行为改变的影响,可作为临床和生活方式咨询的有用工具。
- 原文指出观察到的AMH差异与真实卵巢储备之间关系的性质仍有待评估。
局限性
- 所有决定因素的效应量均存在异质性。
- 观察到的AMH差异与真实卵巢储备之间关系的性质仍有待评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Levels of anti-Müllerian hormone (AMH) are known to be associated with lifestyle determinants such as smoking and oral contraception (OC) use. When measuring AMH in clinical practice, it is essential to know which factors may influence circulating levels or ovarian reserve in general. OBJECTIVE AND RATIONALE: To date, there is no systematic review or summarizing consensus of the nature and magnitude of the relation between AMH and modifiable lifestyle factors. The purpose of this review was to systematically assess the evidence on association of lifestyle behaviors with circulating AMH levels. SEARCH METHODS: We performed a pre-registered systematic review of publications in Embase and PubMed on the lifestyle factors BMI, smoking, OC use, alcohol consumption, caffeine consumption, physical activity, and waist-hip ratio (WHR) in relation to circulating AMH levels up to 1 November 2023. The search strategy included terms such as 'Anti-Mullerian hormone', 'lifestyle', and 'women'. Studies were considered eligible if the association between at least one of the lifestyle factors of interest and AMH was assessed in adult women. The quality of included studies was assessed using the Study Quality Assessment Tools of the National Heart, Lung, and Blood Institute. The results were presented as ranges of the most frequently used association measure for studies that found a significant association in the same direction. OUTCOMES: A total of 15 072 records were identified, of which 65 studies were eligible for inclusion, and 66.2% of the studies used a cross-sectional design. The majority of studies investigating BMI, smoking, OC use, and physical activity reported significant inverse associations with AMH levels. For WHR, alcohol, and caffeine use, the majority of studies did not find an association with AMH. For all determinants, the effect measures of the reported associations were heterogeneous. The mean difference in AMH levels per unit increase in BMI ranged from -0.015 to -0.2 ng/ml in studies that found a significant inverse association. The mean difference in AMH levels for current smokers versus non-smokers ranged from -0.4 to -1.1 ng/ml, and -4% to -44%, respectively. For current OC use, results included a range in relative mean differences in AMH levels of -17% to -31.1%, in addition to a decrease of 11 age-standardized percentiles, and an average decrease of 1.97 ng/ml after 9 weeks of OC use. Exercise interventions led to a decrease in AMH levels of 2.8 pmol/l to 13.2 pmol/l after 12 weeks in women with polycystic ovary syndrome or a sedentary lifestyle. WIDER IMPLICATIONS: Lifestyle factors are associated with differences in AMH levels and thus should be taken into account when interpreting individual AMH measurements. Furthermore, AMH levels can be influenced by the alteration of lifestyle behaviors. While this can be a helpful tool for clinical and lifestyle counseling, the nature of the relation between the observed differences in AMH and the true ovarian reserve remains to be assessed. REGISTRATION NUMBER: PROSPERO registration ID: CRD42022322575.
引用
- Werner L, van der Schouw YT, de Kat AC, et al. A systematic review of the association between modifiable lifestyle factors and circulating anti-Müllerian hormone. Hum Reprod Update. 2024. PMID: 38402486. doi:10.1093/humupd/dmae004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。